Literature DB >> 34494336

Severe acute respiratory syndrome-2 encodes hemagglutinin esterase?

Milad Zandi1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34494336      PMCID: PMC8646382          DOI: 10.1002/rmv.2294

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


× No keyword cloud information.
severe acute respiratory syndrome severe acute respiratory syndrome‐2 Dear Editor I read with interest the article by AL‐Eitan et al. of Pharmacogenomics of genetic polymorphism within the genes responsible for severe acute respiratory syndrome‐2 (SARS‐CoV‐2) susceptibility and the drug‐metabolising genes used in treatment. I appreciate their article, however, the authors reported that “Structural proteins in SARS‐CoV‐2 particles, include spike glycoprotein (S), envelope protein (E), membrane protein (M), nucleocapsid protein (N) and hemagglutinin‐esterase protein (HE)”; in addition, the authors presented HE as a structural protein of SARS‐CoV‐2 in fig. 1a. But based on scientific evidence, the genome of SARS‐CoV‐2 as a Betacoronavirus of Sarbecovirus (lineage B) lacks HE gene , , ; thus, SARS‐CoV‐2 encodes four structural proteins: S, E, M and N. , Phylogenetic analysis showed that the SARS‐CoV‐2 fell within the subgenus Sarbecovirus (lineage B) of the genus Betacoronavirus. Viruses in subgenus Sarbecovirus such as SARS‐CoV‐2 and SARS‐CoV cannot encode HE; however, HKU1‐CoV, OC43‐CoV, murine hepatitis virus and Bovine‐CoV as subgenus Embecovirus (lineage A) of genus Betacoronavirus encode five structural proteins: S, E, M, and N and HE. , In conclusion, SARS‐CoV‐2, the causative agent of the Covid‐19, lacks HE protein.

AUTHOR CONTRIBUTION

Conceptualisation, supervision, writing‐original draft, visualisation, writing‐review and editing: Milad Zandi.
  2 in total

1.  Comment on "COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality."

Authors:  Ahmad Hosseinzadeh Adli; Sanaz Baghban Rahimi
Journal:  Biomed Pharmacother       Date:  2022-08-01       Impact factor: 7.419

2.  Ribosome Profiling: A Useful Approach to Discover Hidden Corners of SARS-CoV-2.

Authors:  Milad Zandi; Emad Behboudi; Parisa Zeinali; Saber Soltani; Mohammad Reza Shojaei
Journal:  Cell J       Date:  2022-02       Impact factor: 3.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.